Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Ally Financial
ALLY
5
Bank of America
BAC
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -176.82%-1.31M | 13.91%-164.73K | -322.57%-415.41K | -1,567.20%-375.99K | -119.73%-353.74K | -115.75%-473.19K | -143.37%-191.34K | -104.09%-98.3K | 66.69%-22.55K | -548.23%-160.99K |
Net income from continuing operations | -146.96%-1.1M | 20.24%-123.34K | -182.37%-281.63K | -284.15%-432.85K | -235.07%-261.11K | -0.33%-444.98K | 19.18%-154.64K | 49.62%-99.74K | -135.20%-112.68K | -1,144.23%-77.93K |
Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Change In working capital | -647.78%-210.94K | -12.77%-41.39K | -9,428.80%-133.78K | -36.90%56.87K | -11.52%-92.63K | -137.50%-28.21K | -132.56%-36.71K | 65.21%1.43K | 555.43%90.13K | -347.25%-83.06K |
-Change in receivables | -39.50%-60.03K | ---- | ---- | ---- | ---- | ---43.04K | ---- | ---- | ---- | ---- |
-Change in prepaid assets | 172.47%89.97K | ---- | ---- | ---- | ---- | ---124.15K | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | -273.31%-240.87K | ---- | ---- | ---- | ---- | --138.98K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -176.82%-1.31M | 13.91%-164.73K | -322.57%-415.41K | -1,567.20%-375.99K | -119.73%-353.74K | -115.75%-473.19K | -143.37%-191.34K | -104.09%-98.3K | 66.69%-22.55K | -548.23%-160.99K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -281.31K | -96.69K | 0 | 0 | -184.63K | 0 | 0 | 0 | 0 | 0 |
Net PPE purchase and sale | ---281.31K | ---96.69K | --0 | --0 | ---184.63K | --0 | --0 | --0 | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---281.31K | ---96.69K | --0 | --0 | ---184.63K | --0 | --0 | --0 | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -96.78%64.25K | 0 | 28K | 0 | 36.25K | 478.73%2M | 49,824.13%2M | 0 | 0 | 0 |
Net common stock issuance | --0 | -103.07%-64.25K | --28K | --0 | --36.25K | 424.00%2.1M | --2.1M | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | --64.25K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | -80.26%-99.04K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -96.78%64.25K | --0 | --28K | --0 | --36.25K | 478.73%2M | 49,824.13%2M | --0 | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | 215.94%2.23M | 127.44%963.92K | 158.82%1.35M | 217.13%1.73M | 215.94%2.23M | 21.68%705.65K | -45.68%423.81K | 7.13%522.11K | -1.88%544.66K | 21.68%705.65K |
Current changes in cash | -200.21%-1.53M | -114.48%-261.42K | -294.09%-387.41K | -1,567.20%-375.99K | -211.89%-502.12K | 1,111.85%1.52M | 2,519.69%1.81M | -133.56%-98.3K | 66.69%-22.55K | -548.21%-160.99K |
End cash Position | -68.49%702.5K | -68.49%702.5K | 127.44%963.92K | 158.82%1.35M | 217.13%1.73M | 215.94%2.23M | 215.94%2.23M | -45.68%423.81K | 7.13%522.11K | -1.88%544.66K |
Free cash from | -236.27%-1.59M | -36.62%-261.42K | -322.57%-415.41K | -1,567.20%-375.99K | -234.41%-538.37K | -115.75%-473.19K | -143.37%-191.34K | -104.09%-98.3K | 66.69%-22.55K | -548.23%-160.99K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.